FDA Adverse Event Injury Summary report: N

PIRANHA

MDR report key: 18926173 · Received March 18, 2024

Report

Report Number
2124215-2024-15575
Event Type
Injury
Date Received
March 18, 2024
Date of Event
January 12, 2022
Report Date
April 23, 2024
Manufacturer
BOSTON SCIENTIFIC CORPORATION
Product Code
FCL
UDI-DI
08714729302599
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
NY, US
Reporter Occupation
PHYSICIAN
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

BLOCK B3: THE EXACT EVENT ONSET DATE IS UNKNOWN. THE PROVIDED EVENT DATE OF (B)(6) 2022, WAS CHOSEN AS THE BEST ESTIMATE BASED ON THE PROCEDURE WHICH HAPPENED SOMETIME IN 2022 AND 11 DAYS POST-PROCEDURE (POD11) ED PRESENTATION FOR INTERMITTENT CHEST PAIN. BLOCKS D4, H4: THE COMPLAINANT WAS UNABLE TO PROVIDE THE SUSPECT DEVICE LOT NUMBER; THEREFORE, THE LOT EXPIRATION AND DEVICE MANUFACTURE DATES ARE UNKNOWN. BLOCK H6: PATIENT CODE E061201 CAPTURES THE REPORTABLE EVENT OF ANGINA. PATIENT CODE E233001 CAPTURES THE REPORTABLE EVENT OF CHEST PAIN. IMPACT CODE F12 CAPTURES THE REPORTABLE EVENT OF SERIOUS INJURY.

Additional Manufacturer Narrative · 0

BLOCK H11: BLOCK A6 HAS BEEN UPDATED BASED ON THE ADDITIONAL INFORMATION RECEIVED ON (B)(6) 2024. BLOCK B3: THE EXACT EVENT ONSET DATE IS UNKNOWN. THE PROVIDED EVENT DATE OF JANUARY 12, 2022, WAS CHOSEN AS THE BEST ESTIMATE BASED ON THE PROCEDURE WHICH HAPPENED SOMETIME IN 2022 AND 11 DAYS POST-PROCEDURE (POD11) ED PRESENTATION FOR INTERMITTENT CHEST PAIN. BLOCKS D4, H4: THE COMPLAINANT WAS UNABLE TO PROVIDE THE SUSPECT DEVICE LOT NUMBER; THEREFORE, THE LOT EXPIRATION AND DEVICE MANUFACTURE DATES ARE UNKNOWN. BLOCK H6: PATIENT CODE E061201 CAPTURES THE REPORTABLE EVENT OF ANGINA. PATIENT CODE E233001 CAPTURES THE REPORTABLE EVENT OF CHEST PAIN. IMPACT CODE F12 CAPTURES THE REPORTABLE EVENT OF SERIOUS INJURY.

Description of Event or Problem · 0

NOTE: THIS MANUFACTURER REPORT PERTAINS TO THE FIRST OF TWO EVENTS REPORTED BY THE SAME PATIENT. IT WAS REPORTED TO BOSTON SCIENTIFIC CORPORATION THAT A PIRANHA BIOPSY FORCEPS WAS USED DURING CYSTOURETHROSCOPY AND URETEROSCOPY WITH BIOPSY AND HOLMIUM LASER RESECTION OF LEFT RENAL PELVIS TUMOR PROCEDURE PERFORMED SOMETIME IN 2022. DURING THE PROCEDURE, THE ACQUISITION OF THE BIOPSY SPECIMEN WAS ADEQUATE. 11 DAYS POST-PROCEDURE (POD11), THE PATIENT PRESENTED TO THE EMERGENCY DEPARTMENT (ED) FOR INTERMITTENT CHEST PAIN. THE PATIENT HAD SYMPTOMS SIGNIFICANT FOR UNSTABLE ANGINA STATUS POST CARDIAC CATHETERIZATION SHOWING NONOBSTRUCTIVE DISEASE. PER PHYSICIAN'S ASSESSMENT, THE EVENT WAS SERIOUS, WAS NOT RELATED TO THE DEVICE, AND POSSIBLY RELATED TO THE PROCEDURE.

Description of Event or Problem · 0

NOTE: THIS MANUFACTURER REPORT PERTAINS TO THE FIRST OF TWO EVENTS REPORTED BY THE SAME PATIENT. IT WAS REPORTED TO BOSTON SCIENTIFIC CORPORATION THAT A PIRANHA BIOPSY FORCEPS WAS USED DURING CYSTOURETHROSCOPY AND URETEROSCOPY WITH BIOPSY AND HOLMIUM LASER RESECTION OF LEFT RENAL PELVIS TUMOR PROCEDURE PERFORMED SOMETIME IN 2022. DURING THE PROCEDURE, THE ACQUISITION OF THE BIOPSY SPECIMEN WAS ADEQUATE. 11 DAYS POST-PROCEDURE (POD11), THE PATIENT PRESENTED TO THE EMERGENCY DEPARTMENT (ED) FOR INTERMITTENT CHEST PAIN. THE PATIENT HAD SYMPTOMS SIGNIFICANT FOR UNSTABLE ANGINA STATUS POST CARDIAC CATHETERIZATION SHOWING NONOBSTRUCTIVE DISEASE. PER PHYSICIAN'S ASSESSMENT, THE EVENT WAS SERIOUS, WAS NOT RELATED TO THE DEVICE, AND POSSIBLY RELATED TO THE PROCEDURE.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
2277228 PIRANHA FORCEPS, BIOPSY, NON-ELECTRIC FCL BOSTON SCIENTIFIC CORPORATION M0065051600 08714729302599

Patients

Seq Age Sex Outcome Treatment
1 66 YR Male Other